Individuals with high epithelial EZH2 and lower ER expression had a fourfold increased risk of breast cancer development (OR = 4.02, 95% CI = 1.29 –12.59) compared with those who had low EZH2 and ER expression. This evidence concerns the gene EZH2 and breast carcinoma.